Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome

被引:71
作者
Chen, Ji [1 ,2 ]
Zhang, Yangde [1 ]
Deng, Zhansheng [3 ]
机构
[1] Cent South Univ, Natl Hepatobiliary & Enter Surg Res Ctr, Minist Hlth, Changsha 410008, Hunan, Peoples R China
[2] Baogang Hosp, Affiliated Hosp 3, Inner Mongolia Med Coll, Digest Syst Dept, Baotou 014010, Peoples R China
[3] Cent South Univ, Dept Orthoped, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China
关键词
Irritable bowel syndrome; Intestinal mucosa; Th1/Th2; Cytokine; CELLS; RESPONSES; MODEL;
D O I
10.1186/1471-230X-12-91
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background: Irritable bowel syndrome (IBS) is a common functional bowel disorder. The post-infectious IBS (PI-IBS) occurs in IBS patients with a history of intestinal infection preceding the onset of symptoms. However, the underlying cause of PI-IBS is not fully understood, and the purpose of this study was to investigate the immune regulatory mechanism of PI-IBS. Methods: Participants enrolled in this study were divided into three groups including PI-IBS patients (n = 20), IBS patients without a history of infection (non-PI-IBS, n = 18), and healthy controls (n = 20). The expression levels of the Th1-derived cytokines IFN-gamma and IL-12, and the Th2-derived cytokines IL-4 and IL-10 in the mucosal specimens, and in the ascending colon, the descending colon, and the rectal segments were measured by RT-PCR and western blot. Results: The IFN-gamma mRNA levels in the intestinal mucosa were significantly higher in the PI-IBS group than in the non-PI-IBS or control group (both P < 0.05), but there was no difference between the non-PI-IBS and control groups. A trend toward IFN-gamma protein upregulation was found in the PI-IBS group, while the IL-12 and IL-4 mRNA and protein levels were not different between any groups. The IL-10 mRNA and protein levels in the PI-IBS group were both significantly lower than in the non-PI-IBS or control groups (P< 0.05, respectively), but there was no difference between the non-PI-IBS and control groups. There were no differences in the cytokine mRNA and protein levels among the ascending colon, the descending colon, and the rectum of all groups. Conclusions: An increase in IFN-gamma levels and a decrease in IL-10 levels were found in the intestinal mucosa of PI-IBS patients, suggesting that the infection may affect the Th1/Th2 balance. Thus, the dysregulation of the immune response is likely an important cause of IBS.
引用
收藏
页数:6
相关论文
共 20 条
[1]
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology [J].
Baumgart, Daniel C. ;
Carding, Simon R. .
LANCET, 2007, 369 (9573) :1627-1640
[2]
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron [J].
Bellini, M ;
Rappelli, L ;
Blandizzi, C ;
Costa, F ;
Stasi, C ;
Colucci, R ;
Giannaccini, G ;
Marazziti, D ;
Betti, L ;
Baroni, S ;
Mumolo, MG ;
Marchi, S ;
Del Tacca, M .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (12) :2705-2711
[3]
Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction [J].
Bercík, P ;
Wang, L ;
Verdü, EF ;
Mao, YK ;
Blennerhassett, P ;
Khan, WI ;
Kean, I ;
Tougas, G ;
Collins, SM .
GASTROENTEROLOGY, 2004, 127 (01) :179-187
[4]
Diagnosis of irritable bowel syndrome [J].
Coffin, B. .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 :S9-S16
[5]
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study [J].
Corinaldesi, R. ;
Stanghellini, V. ;
Cremon, C. ;
Gargano, L. ;
Cogliandro, R. F. ;
De Giorgio, R. ;
Bartesaghi, G. ;
Canovi, B. ;
Barbara, G. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (03) :245-252
[6]
Mucosal Immune Activation in Irritable Bowel Syndrome: Gender-Dependence and Association With Digestive Symptoms [J].
Cremon, Cesare ;
Gargano, Luciana ;
Morselli-Labate, Antonio M. ;
Santini, Donatella ;
Cogliandro, Rosanna F. ;
De Giorgio, Roberto ;
Stanghellini, Vincenzo ;
Corinaldesi, Roberto ;
Barbara, Giovanni .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (02) :392-400
[7]
Intestinal mast cells in gut inflammation and motility disturbances [J].
De Winter, Benedicte Y. ;
van den Wijngaard, Rene M. ;
de Jonge, Wouter J. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (01) :66-73
[8]
Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker? [J].
Dinan, TG ;
Quigley, EMM ;
Ahmed, SMM ;
Scully, P ;
O'Brien, S ;
O'Mahony, L ;
O'Mahony, S ;
Shanahan, F ;
Keeling, PWN .
GASTROENTEROLOGY, 2006, 130 (02) :304-311
[9]
Abdominal pain in Irritable Bowel Syndrome: A review of putative psychological, neural and neuro-immune mechanisms [J].
Elsenbruch, Sigrid .
BRAIN BEHAVIOR AND IMMUNITY, 2011, 25 (03) :386-394
[10]
Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome [J].
Feng, Bin ;
La, Jun Ho ;
Schwartz, Erica S. ;
Gebhart, G. F. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 302 (10) :G1085-G1098